Arthur Tsang

Arthur Tsang

Arthur Tsang is an assistant researcher in tech innovation at Our Hong Kong Foundation. He read political economy at the London School of Economics and is keen on formulating the right industrial policies for infant industries.

Show more

Latest from Arthur Tsang

The View | How Hong Kong can build on its strengths to become a global biotech data hub

The city is a major financing centre for biotechnology; it must now cement its reputation as a research hub. It already has two key advantages: world-class universities and a wealth of clinical and medical data.

The city is a major financing centre for biotechnology; it must now cement its reputation as a research hub. It already has two key advantages: world-class universities and a wealth of clinical and medical data.

15 Sep 2022 - 6:45AM
The View | To become a tech hub, Hong Kong must unleash the power of university researchers

On the mainland, a strong focus on research, and entrepreneurial spirit within academia have driven the country’s success as a breeding ground for innovation. In Hong Kong, technology development has been sluggish and entrepreneurship is less encouraged among university researchers. This must change.

On the mainland, a strong focus on research, and entrepreneurial spirit within academia have driven the country’s success as a breeding ground for innovation. In Hong Kong, technology development has been sluggish and entrepreneurship is less encouraged among university researchers. This must change.

11 Aug 2022 - 2:15PM
Opinion | Tale of two vaccines: AstraZeneca’s road to success offers lessons for Hong Kong’s biotech ambitions

An HKU team was one of the first to come up with a potential vaccine, but its bumpy development process makes one thing clear: Hong Kong has the talent but not the ecosystem to bring biotechnological breakthroughs to market.

An HKU team was one of the first to come up with a potential vaccine, but its bumpy development process makes one thing clear: Hong Kong has the talent but not the ecosystem to bring biotechnological breakthroughs to market.

8 Jan 2022 - 7:15AM